ArticleBMC public health2025
Is the association between graded sickness absence and return to work confounded by health? A longitudinal cohort study from the Norwegian neck and back registry.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundMusculoskeletal disorders (MSD) are among the leading causes of sickness absence (SA) and disability. Graded sickness absence (GSA) as an alternative to full time sickness absence (FSA) has been implemented in the Nordic countries to promote return to work (RTW) and prevent disability, similar to the Fit Note in the UK. However, the evidence of the effects of GSA on RTW is limited. FSA is plausibly associated with more health problems than GSA. The aim is to investigate if the hypothesized benefits of GSA over FSA on RTW is confounded by health in a cohort of sick listed patients referred to secondary care due to MSD.
methodsData was obtained from the Norwegian Neck and Back Register and the Norwegian Labour and Welfare Administration. Poisson regression was used to estimate the association of GSA versus FSA on RTW at 12 months after assessment, with and without adjustment for measures of symptom severity.
resultsA total of 3371 patients were on GSA (n = 1671, 49.6%) or FSA (n = 1700, 50.4%) at baseline. Patients on FSA reported more severe symptoms than those on GSA on all measures, and detailed analysis of GSA indicated more severe symptoms with higher SA levels. Patients on GSA had higher rates of RTW at 12 months follow up than patients on FSA (unadjusted RR = 1.29, 95% CI 1.22-1.37), and the association remained in the fully adjusted model (RR = 1.19, 95% CI 1.12-1.26). We found an association between levels of GSA and RTW rates, with more work being associated with higher RR for RTW.
conclusionsAmong sick listed patients referred to secondary care due to MSD, GSA is associated with higher rates of RTW than FSA. Some of the beneficial association between GSA and RTW is confounded by higher symptom levels in FSA than GSA patients, but most of the benefit remains after adjusting for symptom severity. Mechanisms for the benefit of GSA remains unknown.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.